Login
Toggle navigation
Videos
Categories
Trending
Dr. Darrell Kohli - Residency at Mayo Clinic
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Residents describe their training experience at Mayo Clinic's Department of Ophthalmol
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
00:10:00
Empowering Europe's Future: Mina do Barroso Lithium Project
00:10:00
Streamlining Tax Filing with Mercadian's TaxCaddy Integration
00:10:00
Creactives Group Explores AI Challenges in the Supply Chain | Paolo Gamberoni, CEO , Creactives Group S P A.
00:10:00
TechCentral Impact Series: Evolution of Cybersecurity with CYBER1 Solutions and Palo Alto Networks | Robert Brown, CEO, Cyber Security 1 ABCYB1:STO
00:10:00
Seed and seed stage firm investing in health, climate and empowerment|Adam Besvinick, Partner,Looking Glass Capital
00:10:00
empower consumers to live on their terms|David Wu,General Partner,Maveron
00:10:00
Adventure Box CEO Christopher Kingdon Discusses Q1 Report and Rising Interest Amid Pandemic | Christopher Kingdon, CEO, Adventure Box Technology AB.
00:10:00
Thaicom CEO Suphajee Suthumpun discusses the convergence of satellite, broadcasting, and broadband technologies.
00:10:00
focused on Applied Artificial Intelligence, and the first VC firm|Nicolai Wadstrom,Founder and General Partner,BootstrapLabs
00:10:00
Discussion on the Post-Pandemic Business Landscape with Nordic Capital's COO | Klas Tikkanen , COO, Nordic Capital.
00:10:00
Digbee CEO Jamie Strauss on Simplifying ESG Disclosure for Mining Companies